These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19627613)

  • 1. Genomic imbalances in precancerous tissues signal oral cancer risk.
    Garnis C; Chari R; Buys TP; Zhang L; Ng RT; Rosin MP; Lam WL
    Mol Cancer; 2009 Jul; 8():50. PubMed ID: 19627613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple aberrations of chromosome 3p detected in oral premalignant lesions.
    Tsui IF; Rosin MP; Zhang L; Ng RT; Lam WL
    Cancer Prev Res (Phila); 2008 Nov; 1(6):424-9. PubMed ID: 19138989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress risk assessment of oral premalignant lesions with saliva miRNA analysis.
    Yang Y; Li YX; Yang X; Jiang L; Zhou ZJ; Zhu YQ
    BMC Cancer; 2013 Mar; 13():129. PubMed ID: 23510112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias.
    Tsui IF; Poh CF; Garnis C; Rosin MP; Zhang L; Lam WL
    Int J Cancer; 2009 Nov; 125(9):2219-28. PubMed ID: 19623652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesions.
    Guillaud M; Zhang L; Poh C; Rosin MP; MacAulay C
    Cancer Res; 2008 May; 68(9):3099-107. PubMed ID: 18451134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis.
    Bhattacharya A; Roy R; Snijders AM; Hamilton G; Paquette J; Tokuyasu T; Bengtsson H; Jordan RC; Olshen AB; Pinkel D; Schmidt BL; Albertson DG
    Clin Cancer Res; 2011 Nov; 17(22):7024-34. PubMed ID: 22068658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
    Rosin MP; Cheng X; Poh C; Lam WL; Huang Y; Lovas J; Berean K; Epstein JB; Priddy R; Le ND; Zhang L
    Clin Cancer Res; 2000 Feb; 6(2):357-62. PubMed ID: 10690511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique FISH patterns associated with cancer progression of oral dysplasia.
    Poh CF; Zhu Y; Chen E; Berean KW; Wu L; Zhang L; Rosin MP
    J Dent Res; 2012 Jan; 91(1):52-7. PubMed ID: 21990607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions.
    Carenzo A; Serafini MS; Roca E; Paderno A; Mattavelli D; Romani C; Saintigny P; Koljenović S; Licitra L; De Cecco L; Bossi P
    Cells; 2020 Aug; 9(8):. PubMed ID: 32756466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity (LOH) profiles--validated risk predictors for progression to oral cancer.
    Zhang L; Poh CF; Williams M; Laronde DM; Berean K; Gardner PJ; Jiang H; Wu L; Lee JJ; Rosin MP
    Cancer Prev Res (Phila); 2012 Sep; 5(9):1081-9. PubMed ID: 22911111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurring DNA copy number gain at chromosome 9p13 plays a role in the activation of multiple candidate oncogenes in progressing oral premalignant lesions.
    Towle R; Tsui IF; Zhu Y; MacLellan S; Poh CF; Garnis C
    Cancer Med; 2014 Oct; 3(5):1170-84. PubMed ID: 25060540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, Canada.
    Cromwell I; Regier DA; Peacock SJ; Poh CF
    Oncologist; 2016 Sep; 21(9):1099-106. PubMed ID: 27401887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy.
    Rangel R; Pickering CR; Sikora AG; Spiotto MT
    Front Immunol; 2022; 13():840923. PubMed ID: 35154165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of chromosomal changes in potentially malignant and malignant oral mucosal lesions from South and South-East Asia using array-comparative genomic hybridization.
    Lunde ML; Roman E; Warnakulasuriya S; Mehrotra R; Laranne J; Vasstrand EN; Ibrahim SO
    Cancer Genomics Proteomics; 2014; 11(3):127-40. PubMed ID: 24969693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomic hybridization reveals genetic progression of oral squamous cell carcinoma from dysplasia via two different tumourigenic pathways.
    Noutomi Y; Oga A; Uchida K; Okafuji M; Ita M; Kawauchi S; Furuya T; Ueyama Y; Sasaki K
    J Pathol; 2006 Sep; 210(1):67-74. PubMed ID: 16767698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer.
    Garnis C; Coe BP; Ishkanian A; Zhang L; Rosin MP; Lam WL
    Genes Chromosomes Cancer; 2004 Jan; 39(1):93-8. PubMed ID: 14603447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomas.
    Shahnavaz SA; Regezi JA; Bradley G; Dubé ID; Jordan RC
    J Pathol; 2000 Mar; 190(4):417-22. PubMed ID: 10699989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis.
    Sawhney M; Rohatgi N; Kaur J; Gupta SD; Deo SV; Shukla NK; Ralhan R
    Oral Oncol; 2007 May; 43(5):515-22. PubMed ID: 16996781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The identification of significant chromosomal regions correlated with oral tongue cancer progression.
    Kim KY; Cha IH
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1667-77. PubMed ID: 22638883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gain of hTERC: a genetic marker of malignancy in oral potentially malignant lesions.
    Dorji T; Monti V; Fellegara G; Gabba S; Grazioli V; Repetti E; Marcialis C; Peluso S; Di Ruzza D; Neri F; Foschini MP
    Hum Pathol; 2015 Sep; 46(9):1275-81. PubMed ID: 26170010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.